AstraZeneca told if their vaccine against the new strain of coronavirus will be effective

Some residents of the UK, where a new type of coronavirus is now spreading, are worried that

the AstraZeneca vaccine, which is being developed inOxford University may not be as good as Pfizer's vaccine. Partial results suggest that AstraZeneca is approximately 70% effective in preventing diseases caused by coronavirus infection, compared to the 95% effectiveness reported by Pfizer and its German partner BioNTech.

However, the CEO of AstraZenecaPascal Sorio told the Sunday Times that researchers have come up with a "winning formula" that makes their vaccine as effective as competing candidates.

“We think we've figured out the winning formula and how to achieve an effectiveness that, after two doses, is not inferior to everyone else,” Sorio said. "I can't tell you more now."

The UK government states thatregulators are reviewing the final data from Phase 3 clinical trials of AstraZeneca. The Times and other media outlets report that vaccine approval can be expected by Thursday. The vaccines can begin to be distributed to the UK population in the first week of January.

When asked about the effectiveness of the vaccine againsta new strain of coronavirus, Sorio said: “For now, we think the vaccine should remain effective. But we can't be sure, so we're going to check it out. "

British authorities blamed new straincoronavirus in a sharp increase in the incidence of the country. It turned out to be much more viral, but authorities emphasize that there is no evidence that it causes a more severe course of COVID-19.

Many countries quickly banned entry from the UK, but since then, cases of the new strain have been reported in a dozen locations around the world.

Read also

Abortion and science: what will happen to the children who will give birth

Check out the most beautiful pictures of Hubble. What has the telescope seen in 30 years?

NASA published a photo of the Earth from the moon, which was taken in 1968